A5002483198- Gastrointestinal disorders and treatments
- Diabetes Treatment and Management
- Diet and metabolism studies
- Gastrointestinal Tumor Research and Treatment
- Gastrointestinal Bleeding Diagnosis and Treatment
- Diabetes and associated disorders
- Vascular Malformations and Hemangiomas
- Bird parasitology and diseases
- Helicobacter pylori-related gastroenterology studies
- Parasite Biology and Host Interactions
- Pancreatic function and diabetes
- Histiocytic Disorders and Treatments
- Leech Biology and Applications
- Nonmelanoma Skin Cancer Studies
- Cancer and Skin Lesions
Okayama Medical Center
2020-2023
National Hospital Organization
2020-2022
Abstract This paper presents a case with type 2 diabetes mellitus on very‐low‐carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium‐glucose cotransporter inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of low‐carbohydrate and provide intensive guidance to prevent EDKA.
A 31-year-old man presented with a feeling of compression and intermittent pain in the epigastrium. He had eaten sliced raw fish (sashimi) for dinner at 10 pm on previous night developed epigastric symptoms 2 hours thereafter. Physical examination revealed no tenderness or rebound epigastrium; his vital signs laboratory parameters were normal. reported history similar when he gastric anisakiasis; therefore, esophagogastroduodenoscopy (EGD) was conducted. This an Anisakis larva invading...
The Glasgow-Blatchford score (GBS) is a widely used risk assessment tool for patients with upper gastrointestinal bleeding. However, it only identifies relatively low proportion of at adverse events and poor outcomes. We developed simple diagnostic algorithm combining the GBS nasogastric aspirate evaluated its performance.A total 115 consecutive suspected nonvariceal bleeding who underwent tube placement endoscopy our emergency department were prospectively evaluated. compared accuracy...
This paper presents a case with type 2 diabetes mellitus on very low-carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium-glucose cotransporter inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of and provide intensive guidance to prevent EDKA.